Interestingly, there was no significant difference in the tumor progression kinetics (Figure 7A–C) upon anti-CTLA4 treatment in wild-type and CD4-NFAT5-KO transgenic mice in NS and LS diet cohorts. This evidence concerns the gene CTLA4 and neoplasm.